But here’s an entirely personal list of 10 that I think should never have been resurrected.

EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Gearing Up for Phase 2 Vitiligo Trial in Mid-2026 Edesa Biotech, Inc.

XRP has a clear case to retest much higher levels as liquidity, regulation, and usage align. It is a credible large-cap hold ...